DOSSIER · 13F-HR · Q2 2026

Andera Partners

$206M in tracked AUM across 8 positions as of Q2 2026.

AP
CIK 0001757283 · last filed Jun 30, 2026
Total AUM
$206M
as of Q2 2026
Holdings
8
positions
Whale Score
69
69
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Andera Partners filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
G52441105
KESTRA MED TECHNOLOGIES LTD
$69M2.7M33.6%
02
MLYS
MINERALYS THERAPEUTICS INC
$43M1.6M20.8%
03
AVLN
AVALYN PHARMACEUTICALS INC
$31M930K14.8%
04
AGMB
AGOMAB THERAPEUTICS NV
$20M1.5M9.7%
05
EVMN
EVOMMUNE INC
$18M1.4M9.0%
06
IVA
INVENTIVA SA
$14M3.6M6.7%
07
ABVX
ABIVAX SA
$10M78K5.0%
08
B6S7WD106
NYXOAH S A
$882K522K0.4%

Filing history

2026Q2Jun 30
$206M 16.7%
8 positionsView →
2026Q1Mar 31
$177M 0.2%
7 positionsView →
2025Q4Dec 31
$177M
5 positionsView →